Wake Forest Baptist Medical Center: Changing Cancer Care, One Organoid at a Time
January 22, 2020
January 22, 2020
WINSTON-SALEM, North Carolina, Jan. 22 -- The Wake Forest Baptist Medical Center issued the following news release:
A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine (WFIRM) researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments. The hope is that, one day, these tumor organoids will be used to personalize patients' treatments, to focus on those that will best help them . . .
A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine (WFIRM) researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments. The hope is that, one day, these tumor organoids will be used to personalize patients' treatments, to focus on those that will best help them . . .